Japan Clinical Oncology Group
22
5
5
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
18.2%
4 terminated/withdrawn out of 22 trials
73.3%
-13.2% vs industry average
77%
17 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Role: collaborator
Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer
Role: collaborator
Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
Role: collaborator
Tirabrutinib Maintenance Versus Placebo in Patients With Primary CNS Lymphoma in Complete Remission (JCOG2104)
Role: collaborator
Diffusion-Weighted MRI for Liver Metastasis
Role: collaborator
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
Role: collaborator
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
Role: collaborator
Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
Role: collaborator
A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma
Role: lead
A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer
Role: lead
Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)
Role: lead
A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
Role: lead
Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion
Role: lead
Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)
Role: lead
Elderly NSCLC/D vs DP (JCOG0207)
Role: lead
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Role: lead
A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer
Role: lead
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
Role: lead
Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)
Role: lead
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
Role: lead